Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Bruhn JN, Mihail JD, Pickens JB
Rising AI adoption across drug discovery will accelerate innovation and shorten time-to-market, while certain companies pivot from simple to niche and complex generics
Counterfeit GLP-1 drugs have become, as Katherine Eban wrote in a Vanity Fair investigation, a hot commodity among transnational crime groups, homegrown counterfeiters, rogue compounders, shady middlemen, unscrupulous doctors, and medi-spas of dubious legality. By February, Eban reported, illegal pharmacies in the US were filling more than 734,000 GLP-1 prescriptions per month, according to data compiled by Translucent DataLab, which scrutinizes illegal online pharmacies, and IQVIA, a major data and clinical research company
Give the receptor a brake: slowing gastric emptying by GLP-1
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
